PRNewsWire - Health

Waystar Reports Fourth Quarter and Fiscal Year 2024 Results
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Compugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System